 James Feinstein
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nervous System Diseases | 8 | 2024 | 251 | 3.540 |
Why?
| | Polypharmacy | 10 | 2023 | 83 | 3.100 |
Why?
| | Epidermolysis Bullosa | 8 | 2024 | 59 | 3.060 |
Why?
| | Medicaid | 11 | 2024 | 437 | 2.720 |
Why?
| | International Classification of Diseases | 6 | 2024 | 124 | 2.690 |
Why?
| | Chronic Disease | 12 | 2024 | 1701 | 2.680 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 6 | 2024 | 255 | 2.090 |
Why?
| | Physician-Patient Relations | 6 | 2024 | 530 | 1.680 |
Why?
| | Medication Therapy Management | 3 | 2023 | 72 | 1.630 |
Why?
| | Child | 59 | 2025 | 20721 | 1.430 |
Why?
| | Outpatients | 3 | 2024 | 366 | 1.290 |
Why?
| | Child, Preschool | 34 | 2024 | 10373 | 1.120 |
Why?
| | Delivery of Health Care | 3 | 2023 | 892 | 1.120 |
Why?
| | Drug Interactions | 6 | 2024 | 360 | 1.110 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 151 | 1.000 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2023 | 38 | 0.990 |
Why?
| | Prescription Drugs | 3 | 2017 | 116 | 0.990 |
Why?
| | Infant | 28 | 2024 | 8913 | 0.930 |
Why?
| | Cross-Sectional Studies | 14 | 2024 | 5040 | 0.840 |
Why?
| | Patient Care | 1 | 2024 | 110 | 0.840 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 249 | 0.810 |
Why?
| | Oral Health | 1 | 2024 | 129 | 0.800 |
Why?
| | Adolescent | 34 | 2024 | 20213 | 0.800 |
Why?
| | Cholinergic Antagonists | 1 | 2022 | 29 | 0.800 |
Why?
| | Pediatrics | 6 | 2022 | 1061 | 0.800 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 53 | 0.770 |
Why?
| | Parents | 2 | 2020 | 1306 | 0.770 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 11 | 0.720 |
Why?
| | Drug Utilization | 2 | 2019 | 167 | 0.710 |
Why?
| | Retrospective Studies | 30 | 2024 | 14460 | 0.710 |
Why?
| | Drug Prescriptions | 2 | 2020 | 250 | 0.690 |
Why?
| | Humans | 73 | 2025 | 128524 | 0.690 |
Why?
| | Hospitalization | 6 | 2024 | 2071 | 0.660 |
Why?
| | Symptom Assessment | 1 | 2020 | 125 | 0.650 |
Why?
| | Analgesics | 1 | 2020 | 165 | 0.640 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 757 | 0.640 |
Why?
| | Ambulatory Care | 4 | 2023 | 506 | 0.640 |
Why?
| | Cohort Studies | 13 | 2024 | 5369 | 0.610 |
Why?
| | Pharmaceutical Preparations | 2 | 2023 | 170 | 0.600 |
Why?
| | United States | 22 | 2025 | 13876 | 0.590 |
Why?
| | Drug Costs | 1 | 2019 | 103 | 0.590 |
Why?
| | Critical Illness | 1 | 2024 | 729 | 0.590 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2022 | 620 | 0.560 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 260 | 0.560 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 359 | 0.550 |
Why?
| | Health Priorities | 1 | 2017 | 34 | 0.540 |
Why?
| | Medication Adherence | 1 | 2021 | 573 | 0.520 |
Why?
| | Self-Injurious Behavior | 3 | 2023 | 120 | 0.520 |
Why?
| | Attitude to Death | 4 | 2024 | 68 | 0.510 |
Why?
| | Male | 39 | 2024 | 62883 | 0.490 |
Why?
| | Home Care Services | 3 | 2025 | 245 | 0.490 |
Why?
| | Skin Neoplasms | 1 | 2022 | 832 | 0.470 |
Why?
| | Software | 1 | 2018 | 610 | 0.420 |
Why?
| | Female | 35 | 2024 | 68127 | 0.410 |
Why?
| | Databases, Factual | 7 | 2024 | 1268 | 0.400 |
Why?
| | Terminally Ill | 2 | 2010 | 35 | 0.400 |
Why?
| | Algorithms | 2 | 2022 | 1616 | 0.380 |
Why?
| | Severity of Illness Index | 4 | 2020 | 2736 | 0.370 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 903 | 0.370 |
Why?
| | Caregivers | 5 | 2025 | 807 | 0.370 |
Why?
| | Hospitals, Pediatric | 7 | 2020 | 516 | 0.350 |
Why?
| | Biomedical Research | 1 | 2017 | 646 | 0.350 |
Why?
| | Health Services Research | 3 | 2025 | 389 | 0.340 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2266 | 0.340 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 1968 | 0.330 |
Why?
| | Mortality | 2 | 2009 | 307 | 0.310 |
Why?
| | Professional-Family Relations | 2 | 2009 | 145 | 0.310 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1266 | 0.290 |
Why?
| | Child Mortality | 1 | 2007 | 13 | 0.290 |
Why?
| | Autopsy | 1 | 2007 | 92 | 0.290 |
Why?
| | Patient Preference | 1 | 2010 | 184 | 0.290 |
Why?
| | Terminal Care | 2 | 2011 | 238 | 0.280 |
Why?
| | Child Welfare | 1 | 2007 | 211 | 0.250 |
Why?
| | Cause of Death | 1 | 2007 | 391 | 0.250 |
Why?
| | Medical History Taking | 1 | 2005 | 115 | 0.240 |
Why?
| | Prevalence | 3 | 2024 | 2549 | 0.240 |
Why?
| | Risk Assessment | 5 | 2020 | 3256 | 0.240 |
Why?
| | Infant, Newborn | 9 | 2024 | 5687 | 0.230 |
Why?
| | Education, Medical, Undergraduate | 1 | 2007 | 177 | 0.230 |
Why?
| | House Calls | 1 | 2005 | 123 | 0.230 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1090 | 0.220 |
Why?
| | Ontario | 1 | 2024 | 89 | 0.220 |
Why?
| | Internship and Residency | 2 | 2011 | 1054 | 0.220 |
Why?
| | Pharmacogenomic Testing | 1 | 2024 | 59 | 0.210 |
Why?
| | Family | 1 | 2007 | 642 | 0.210 |
Why?
| | Patient Safety | 3 | 2023 | 290 | 0.210 |
Why?
| | Dental Caries | 1 | 2024 | 156 | 0.210 |
Why?
| | World Health Organization | 1 | 2023 | 109 | 0.210 |
Why?
| | Seizures | 1 | 2005 | 395 | 0.200 |
Why?
| | Mobile Applications | 1 | 2024 | 158 | 0.190 |
Why?
| | Logistic Models | 3 | 2024 | 1975 | 0.190 |
Why?
| | Anemia | 1 | 2023 | 156 | 0.190 |
Why?
| | Patient Discharge | 3 | 2021 | 849 | 0.190 |
Why?
| | Canada | 2 | 2020 | 345 | 0.190 |
Why?
| | Child, Hospitalized | 1 | 2021 | 48 | 0.180 |
Why?
| | Age Factors | 4 | 2021 | 3117 | 0.180 |
Why?
| | Physicians | 1 | 2009 | 860 | 0.180 |
Why?
| | Pseudomonas aeruginosa | 1 | 2023 | 334 | 0.180 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 41 | 0.170 |
Why?
| | Multimorbidity | 1 | 2021 | 46 | 0.170 |
Why?
| | Medication Errors | 2 | 2024 | 95 | 0.170 |
Why?
| | Bronchiolitis | 1 | 2021 | 89 | 0.160 |
Why?
| | Data Collection | 2 | 2020 | 649 | 0.160 |
Why?
| | Critical Care | 1 | 2024 | 544 | 0.160 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 67 | 0.150 |
Why?
| | Programming Languages | 1 | 2018 | 22 | 0.150 |
Why?
| | Biopsy, Needle | 1 | 2019 | 189 | 0.150 |
Why?
| | Dilatation | 1 | 2018 | 59 | 0.150 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 147 | 0.150 |
Why?
| | Esophageal Stenosis | 1 | 2018 | 51 | 0.150 |
Why?
| | Colorado | 2 | 2020 | 4392 | 0.150 |
Why?
| | Suicidal Ideation | 1 | 2023 | 463 | 0.150 |
Why?
| | Fluoroscopy | 1 | 2018 | 155 | 0.150 |
Why?
| | Adult | 9 | 2024 | 35315 | 0.150 |
Why?
| | North America | 1 | 2019 | 289 | 0.150 |
Why?
| | Age Distribution | 1 | 2019 | 376 | 0.150 |
Why?
| | Patient-Centered Care | 1 | 2023 | 493 | 0.150 |
Why?
| | Sex Distribution | 1 | 2019 | 359 | 0.150 |
Why?
| | Vulnerable Populations | 1 | 2019 | 157 | 0.140 |
Why?
| | Young Adult | 7 | 2020 | 12320 | 0.140 |
Why?
| | Palliative Care | 3 | 2011 | 716 | 0.140 |
Why?
| | Case Management | 1 | 2017 | 63 | 0.140 |
Why?
| | Esophagoscopy | 1 | 2018 | 195 | 0.140 |
Why?
| | Child Health | 1 | 2019 | 146 | 0.140 |
Why?
| | Fee-for-Service Plans | 1 | 2017 | 88 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2023 | 704 | 0.140 |
Why?
| | Nursing Staff, Hospital | 2 | 2011 | 149 | 0.140 |
Why?
| | Child Health Services | 3 | 2022 | 185 | 0.140 |
Why?
| | Influenza, Human | 1 | 2023 | 596 | 0.130 |
Why?
| | Managed Care Programs | 1 | 2017 | 133 | 0.130 |
Why?
| | Esophagus | 2 | 2018 | 248 | 0.130 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 335 | 0.130 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 380 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 395 | 0.120 |
Why?
| | Drug Labeling | 1 | 2015 | 40 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1265 | 0.120 |
Why?
| | Drug Therapy, Combination | 2 | 2018 | 1009 | 0.120 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1667 | 0.120 |
Why?
| | Sex Factors | 2 | 2019 | 1949 | 0.120 |
Why?
| | Pneumonia | 1 | 2021 | 599 | 0.120 |
Why?
| | Telemedicine | 1 | 2023 | 778 | 0.120 |
Why?
| | Pain | 1 | 2020 | 756 | 0.120 |
Why?
| | Neoplasms | 1 | 2009 | 2465 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 378 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1669 | 0.110 |
Why?
| | Duodenum | 1 | 2014 | 71 | 0.110 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 153 | 0.110 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2016 | 191 | 0.110 |
Why?
| | Insurance Claim Reporting | 1 | 2014 | 23 | 0.110 |
Why?
| | Utilization Review | 1 | 2014 | 37 | 0.110 |
Why?
| | Stomach | 1 | 2014 | 109 | 0.110 |
Why?
| | Terminology as Topic | 1 | 2015 | 199 | 0.110 |
Why?
| | Biomedical Technology | 1 | 2014 | 39 | 0.110 |
Why?
| | Patient Readmission | 2 | 2021 | 664 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2014 | 120 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2014 | 304 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2005 | 2323 | 0.100 |
Why?
| | Patient Admission | 1 | 2014 | 184 | 0.100 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2014 | 217 | 0.100 |
Why?
| | Quality Improvement | 1 | 2020 | 1100 | 0.100 |
Why?
| | Risk Factors | 4 | 2021 | 9727 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2019 | 4898 | 0.100 |
Why?
| | Incidence | 1 | 2019 | 2619 | 0.100 |
Why?
| | Mental Disorders | 1 | 2020 | 1007 | 0.100 |
Why?
| | Endoscopy, Digestive System | 1 | 2013 | 122 | 0.100 |
Why?
| | Comorbidity | 3 | 2023 | 1540 | 0.090 |
Why?
| | Quality of Life | 1 | 2023 | 2680 | 0.090 |
Why?
| | Organ Transplantation | 1 | 2014 | 219 | 0.090 |
Why?
| | Disease Progression | 1 | 2019 | 2603 | 0.090 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 197 | 0.090 |
Why?
| | Bereavement | 1 | 2011 | 50 | 0.090 |
Why?
| | Health Services Accessibility | 1 | 2017 | 892 | 0.090 |
Why?
| | Anecdotes as Topic | 1 | 2010 | 7 | 0.090 |
Why?
| | Drug Overdose | 1 | 2014 | 330 | 0.080 |
Why?
| | Obesity | 1 | 2023 | 2860 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2007 | 1271 | 0.080 |
Why?
| | Pharmacoepidemiology | 2 | 2019 | 21 | 0.070 |
Why?
| | Domestic Violence | 1 | 2008 | 50 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 1936 | 0.070 |
Why?
| | Shellfish | 1 | 2005 | 6 | 0.060 |
Why?
| | Humanism | 1 | 2005 | 5 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2010 | 612 | 0.060 |
Why?
| | Health Care Surveys | 2 | 2017 | 557 | 0.060 |
Why?
| | Anaphylaxis | 1 | 2005 | 98 | 0.060 |
Why?
| | Residence Characteristics | 1 | 2007 | 324 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 518 | 0.060 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2024 | 29 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2697 | 0.060 |
Why?
| | Food Hypersensitivity | 1 | 2005 | 172 | 0.050 |
Why?
| | Hospitals | 1 | 2007 | 631 | 0.050 |
Why?
| | Communication | 2 | 2023 | 838 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 368 | 0.050 |
Why?
| | Nursing Homes | 1 | 2023 | 151 | 0.050 |
Why?
| | Mupirocin | 1 | 2020 | 7 | 0.050 |
Why?
| | Iron | 1 | 2023 | 281 | 0.040 |
Why?
| | Prognosis | 1 | 2009 | 3780 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2023 | 347 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 633 | 0.040 |
Why?
| | Primary Health Care | 2 | 2022 | 1638 | 0.040 |
Why?
| | Pharmacists | 1 | 2022 | 262 | 0.040 |
Why?
| | Pharmacovigilance | 1 | 2019 | 22 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1358 | 0.040 |
Why?
| | Clinical Competence | 1 | 2005 | 1014 | 0.040 |
Why?
| | Health Expenditures | 1 | 2020 | 184 | 0.040 |
Why?
| | Adolescent Health Services | 1 | 2019 | 76 | 0.040 |
Why?
| | Health Maintenance Organizations | 1 | 2017 | 99 | 0.040 |
Why?
| | Observer Variation | 1 | 2018 | 315 | 0.030 |
Why?
| | Mental Health Services | 1 | 2022 | 399 | 0.030 |
Why?
| | Health Personnel | 1 | 2023 | 646 | 0.030 |
Why?
| | Rural Population | 1 | 2020 | 504 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2020 | 425 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 949 | 0.030 |
Why?
| | Global Health | 1 | 2019 | 326 | 0.030 |
Why?
| | Stomach Diseases | 1 | 2014 | 20 | 0.030 |
Why?
| | Clinical Coding | 1 | 2014 | 20 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 764 | 0.030 |
Why?
| | Mental Health | 1 | 2020 | 684 | 0.030 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2013 | 14 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 30893 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1820 | 0.030 |
Why?
| | Failure to Thrive | 1 | 2013 | 29 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 147 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2013 | 146 | 0.020 |
Why?
| | Celiac Disease | 1 | 2014 | 287 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1085 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7043 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2013 | 232 | 0.020 |
Why?
| | Eosinophilic Esophagitis | 1 | 2014 | 318 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1121 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1494 | 0.020 |
Why?
| | Pennsylvania | 1 | 2009 | 107 | 0.020 |
Why?
| | Nurses | 1 | 2011 | 163 | 0.020 |
Why?
| | Nurse-Patient Relations | 1 | 2007 | 62 | 0.020 |
Why?
| | Regression Analysis | 1 | 2008 | 983 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2009 | 546 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 705 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2009 | 844 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 10163 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 368 | 0.010 |
Why?
|
|
Feinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|